5. Progressive supranuclear palsy Clinical trials / Disease details


Clinical trials : 95 Drugs : 119 - (DrugBank : 40) / Drug target genes : 65 - Drug target pathways : 108

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00385710
(ClinicalTrials.gov)
November 200610/10/2006Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)Randomized Placebo-controlled Trial of Valproic Acid in Patients With Progressive Supranuclear PalsyProgressive Supranuclear PalsyDrug: valproic acid;Drug: PlaceboNantes University HospitalNULLCompleted45 Years75 YearsBoth28Phase 2France